Cargando…

Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer

A minimum of 12 harvested lymph nodes (hLNs) are recommended in colorectal cancer. However, a paucity of hLNs is frequently presented after preoperative chemoradiation (pCRT) in rectal cancer and the significance of this is still uncertain. The aim of this study is to analyze the impact of hLNs on l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Woo Ram, Han, Yoon Dae, Cho, Min Soo, Hur, Hyuk, Min, Byung Soh, Lee, Kang Young, Kim, Nam Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617087/ https://www.ncbi.nlm.nih.gov/pubmed/26181550 http://dx.doi.org/10.1097/MD.0000000000001133

Ejemplares similares

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

MRI pelvimetry-based evaluation of surgical difficulty in laparoscopic total mesorectal excision after neoadjuvant chemoradiation for male rectal cancer
por: Chen, Jianhua, et al.
Publicado: (2021)

Short and Long-Term Outcomes of Robotic versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Case-Matched Retrospective Study
por: Cho, Min Soo, et al.
Publicado: (2015)

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
por: Lee, Sung Hwan, et al.
Publicado: (2015)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
por: Maykel, Justin A., et al.
Publicado: (2022)

Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
por: Gachabayov, M., et al.
Publicado: (2023)

Oncological outcomes after transanal total mesorectal excision for rectal cancer
por: Francis, Nader K, et al.
Publicado: (2023)

Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
por: Lim, Yon Kuei, et al.
Publicado: (2010)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Age-Adjusted Charlson Comorbidity Index Scores as Predictor of Survival in Colorectal Cancer Patients Who Underwent Surgical Resection and Chemoradiation
por: Wu, Chin-Chia, et al.
Publicado: (2015)

Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis
por: Jung, Sung Min, et al.
Publicado: (2016)

Oncologic Outcomes and Risk Factors for Recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases
por: Kim, Sam Hee, et al.
Publicado: (2012)

Voiding Dysfunction after Total Mesorectal Excision in Rectal Cancer
por: Kim, Jae Heon, et al.
Publicado: (2011)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer
por: Han, Jeonghee, et al.
Publicado: (2016)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Factors Influencing Oncologic Outcomes after Tumor-specific Mesorectal Excision for Rectal Cancer
por: Lee, Kil Yeon
Publicado: (2012)

Long-term oncological results after transanal total mesorectal excision for rectal carcinoma
por: Hol, Jeroen C., et al.
Publicado: (2019)

Is the Learning Curve of Robotic Low Anterior Resection Shorter Than Laparoscopic Low Anterior Resection for Rectal Cancer?: A Comparative Analysis of Clinicopathologic Outcomes Between Robotic and Laparoscopic Surgeries
por: Park, Eun Jung, et al.
Publicado: (2014)

Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
por: Kim, Min Jung, et al.
Publicado: (2019)

Laparoscopic Total Mesorectal Excision in a Rectal Cancer Patient with Situs Inversus Totalis
por: Huh, Jung Wook, et al.
Publicado: (2010)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
por: Lee, Yong Joon, et al.
Publicado: (2016)

Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)

Reduced-Port Laparoscopic Surgery for a Tumor-Specific Mesorectal Excision in Patients With Colorectal Cancer: Initial Experience With 20 Consecutive Cases
por: Bae, Sung Uk, et al.
Publicado: (2015)

Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision
por: Ma, Bin, et al.
Publicado: (2016)

Effectiveness of the Apparent Diffusion Coefficient for Predicting the Response to Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Xie, Haiting, et al.
Publicado: (2015)

Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer
por: Lee, Ja Kyung, et al.
Publicado: (2021)

Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy
por: Huang, Long, et al.
Publicado: (2023)

Predictors of surgical outcomes and survival in rectal cancer patients undergoing laparoscopic total mesorectal excision after neoadjuvant chemoradiation therapy: the interest of pelvimetry and restaging magnetic resonance imaging studies
por: de’Angelis, Nicola, et al.
Publicado: (2018)

High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
por: Ke, Te-Min, et al.
Publicado: (2020)

Robotic Total Mesorectal Excision for Rectal Cancer: Short-Term Oncological Outcomes of Initial 178 Cases
por: Ramachandra, C., et al.
Publicado: (2020)

Neoadjuvant therapy of cetuximab combined with chemoradiotherapy in rectal cancer: A single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials
por: Yan, Qi, et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy with capecitabine based regimen in locally advanced rectal cancer: A retrospective study
por: Li, Fei, et al.
Publicado: (2023)

Robotic Total Mesorectal Excision for Rectal Cancer: Current Evidences and Future Perspectives
por: Jang, Je-Ho, et al.
Publicado: (2020)

Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response
por: Belluco, Claudio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uetrsqu8kmnhd1aqmge037slmk